Roxadustat: not just for anemia

HIGHLIGHTS

• who: August and colleagues from the Institute (IRCCS), Italy Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin, China, Physical have published the article: Roxadustat: Not just for anemia, in the Journal: (JOURNAL) of 15/07/2021
• what: Roxadustat is a HIF activator that is approved for the clinical treatment of renal anemia in China, the European Union, Japan, South Korea, and Chile.
• future: Current clinical studies support its efficacy and safety but more in-depth and long-term studies are needed especially before its indications can be expanded. Because inflammation . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.